indium-111-octreotide

Known as: (111)In-octreotide, 111In-octreotide, indium 111 octreotide 
 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2016
2016
The aim of this study was to test the hypothesis that inhibiting mammalian target of rapamycin and insulin-like growth factor-1… (More)
  • table 1
  • table 2
  • figure 3
  • figure 2
  • table 3
Is this relevant?
2011
2011
Carcinoids represent 1-2% of the rectal cancer. We report the case of a woman with a rectal carcinoid and a hypogastric node… (More)
Is this relevant?
Review
2007
Review
2007
Neuroendocrine tumours (NET) are rare tumours that occur most commonly in the GI tract. Various labelled somatostatin analogues… (More)
Is this relevant?
2006
2006
BACKGROUND Tumor-induced hypophosphatemic osteomalacia is a syndrome characterized by urinary phosphate wasting related to the… (More)
Is this relevant?
2003
2003
Aim. Differentiated thyroid cancer is characterized by a very good prognosis in the majority of the patients. The therapy of… (More)
  • table 1
  • table 2
  • figure 1
Is this relevant?
2003
2003
OBJECTIVE To evaluate therapy with high doses of (111)Indium pentetreotide in a patient with bone metastases from a carcinoid of… (More)
Is this relevant?
1998
1998
UNLABELLED The early detection of all tumor sites in patients with medullary thyroid carcinoma (MTC) before primary surgery is… (More)
Is this relevant?
1996
1996
Indium-111-octreotide, a somatostatin analog is the first commercially available receptor-based agent. It shares the binding site… (More)
Is this relevant?